Evofem Biosciences Inc

-0.02 (-3.04%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)104.29M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$3.96 Million
Adjusted EPS-$0.31
See more estimates
10-Day MA$0.73
50-Day MA$0.77
200-Day MA$1.63
See more pivots

Evofem Biosciences Inc Stock, NASDAQ:EVFM

12400 High Bluff Drive, Suite 600, San Diego, California 92130
United States of America
Phone: +1.858.550.1900
Number of Employees: 147


Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company, which develops and commercializes innovative products to unmet needs in women's sexual and reproductive health. Its product includes Phexxi (lactic acid, citric acid and potassium bitartrate) a hormone-free vaginal gel and EVO100 an investigational drug, which is used for urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infection in women. The company was founded in 2007 and is headquartered in San Diego, CA.